Evidence map›Paper›PMID 34279366›Full record

ArticleMolecules (Basel, Switzerland)2021

Reactive Nanoparticles Derived from Polysaccharide Phenyl Carbonates.

Martin Gericke, Katja Geitel, Cornelia Jörke, Joachim H Clement, Thomas Heinze

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Martin GerickeInstitute of Organic Chemistry and Macromolecular Chemistry, Friedrich-Schiller-University of Jena, Humboldtstr 10, 07743 Jena, Germany.ORCID 0000-0002-0273-1996
Katja GeitelDepartment of Hematology and Medical Oncology, Jena University Hospital, Am Klinikum 1, 07747 Jena, Germany.
Cornelia JörkeDepartment of Hematology and Medical Oncology, Jena University Hospital, Am Klinikum 1, 07747 Jena, Germany.
Joachim H ClementDepartment of Hematology and Medical Oncology, Jena University Hospital, Am Klinikum 1, 07747 Jena, Germany.ORCID 0000-0002-6601-2456
Thomas HeinzeInstitute of Organic Chemistry and Macromolecular Chemistry, Friedrich-Schiller-University of Jena, Humboldtstr 10, 07743 Jena, Germany.
Jena University Hospital · DEFriedrich Schiller University Jena · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polysaccharide (PS) based nanoparticles (NP) are of great interest for biomedical applications. A key challenge in this regard is the functionalization of these nanomaterials. The aim of the present work was the development of reactive PS-NP that can be coupled with an amino group containing compounds under mild aqueous conditions. A series of cellulose phenyl carbonates (CPC) and xylan phenyl carbonates (XPC) with variable degrees of substitution (DS) was obtained by homogeneous synthesis. The preparation of PS-NP by self-assembling of these hydrophobic derivatives was studied comprehensively. While CPC mostly formed macroscopic aggregates, XPC formed well-defined spherical NP with diameters around 100 to 200 nm that showed a pronounced long-term stability in water against both particle aggregation as well as cleavage of phenyl carbonate moieties. Using an amino group functionalized dye it was demonstrated that the novel XPC-NP are reactive towards amines. A simple coupling procedure was established that enables direct functionalization of the reactive NP in an aqueous dispersion. Finally, it was demonstrated that dye functionalized XPC-NP are non-cytotoxic and can be employed in advanced biomedical applications.

Indexed as

biocompatibilitydye functionalizationhomogeneous synthesisnanoparticlespolysaccharide derivativesxylan derivatives

Identifiers

PMID34279366
PMCPMC8272227
OpenAlexW3182590177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.